I’d invest £4,200 in this FTSE 250 REIT for £350 in passive income a year

This FTSE 250 REIT offers a massive dividend yield. Our writer outlines how he’d invest in its shares to supplement his income in 2023.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings

Image source: Getty Images

Target Healthcare REIT (LSE: THRL) is one of the top five yielding shares in the FTSE 250 index. The property company operates in the healthcare sector, counting a large number of care homes in its real estate portfolio.

The real estate investment trust (REIT) offers an 8.38% annual dividend yield. This is considerably above the average yields for both the FTSE 100 and FTSE 250.

If I had spare cash to invest, here’s how I’d target £350 in annual passive income by investing in the company.

Dividend income from property

Investing in REITs is a great way to diversify my stock market portfolio. They offer exposure to income-producing real estate in a passive way, allowing me to avoid the headaches that can come from being a landlord.

Target Healthcare is one of the highest yielding REITs in the UK market, so I think it merits serious consideration for my portfolio.

Following a big fall in recent months, the Target Healthcare share price stands at 80.50p as I write. Big share price volatility can create value investment opportunities, and I think this REIT falls into that category. If I had £4,200 to invest in the FTSE 250 stock today, I could buy 5,217 shares.

The share price decline has pushed the dividend yield up. Accordingly, if I invested now, I’d earn a little under £352 in passive income just from holding the shares for a year.

As a long-term investor, I’d be inclined to hold the shares for longer than 12 months. If I reinvested my dividends into more shares, I could begin to benefit from a compounding effect on my investments.

The outlook for Target Healthcare REIT

One reason I’m bullish on Target Healthcare is the demographic transformation underway in the UK. According to the ONS, the number of UK residents aged 65 or older will reach 20.4m by 2066, equating to 26% of the total population. An aging population means increased demand for care provision.

I also like the stock’s defensive qualities. Its lease structures are long term (typically 30-35 years) and inflation linked. It’s also non-cyclical, as demand for social care isn’t dependent on the performance of the wider economy.

In addition, the properties in the group’s portfolio are modern and purpose-built. Medical issues such as incontinence make the provision of en-suite wet rooms an important consideration. Around 96% of the group’s homes have wet rooms, compared to a 29% national comparative.

Target Healthcare also continues to make progress with regards to occupancy rates. After a reduction during the Omicron wave during the pandemic, occupancy levels have climbed since March 2022, according to the company’s latest data. High occupancy is essential for the group’s rental income.

Source: Target Healthcare REIT Annual Report 2022

There are some risks facing the REIT. Dividend cover is a concern at 72%. If the company’s profitability came under pressure, I’m worried the jumbo dividend yield might not be sustainable.

High inflation is another challenge facing the business. Increased costs for staff, building materials, and energy could erode the company’s margins.

Nonetheless, overall I think long-term tailwinds will boost the share price performance. With some spare cash, I’d invest in the REIT to target a regular passive income stream today.

Charlie Carman has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Housing development near Dunstable, UK
Investing Articles

With its 6.5% dividend yield, is ITV a buy for my Stocks and Shares ISA?

ITV's dividend yield is almost twice as high as the FTSE 250 index average. Does this make it a no-brainer…

Read more »

Stacks of coins
Investing Articles

I’m targeting £15,401 in yearly dividends from £20,000 in this FTSE passive income heavyweight

Analysts expect this FTSE 100 gem to keep increasing dividends and generating strong earnings growth. So can it keep turbocharging…

Read more »

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

5%+ dividend yields and P/Es below 11! 2 FTSE 100 shares to consider

The London stock market's bursting with bargains following recent choppiness. Here Royston Wild reveals two cheap FTSE stars that deserve…

Read more »

Diverse group of friends cheering sport at bar together
Investing Articles

8%+ yields! 2 investment trusts to target a £1,640 passive income this new ISA year

Considering these investment trusts could put ISA investors on the fast-track to a large and reliable long-term passive income. Royston…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

Looking for ISA bargains? 4 FTSE 250 value stars to consider

Just like Warren Buffett, I love snapping up quality stocks when they're marked down in price. Here are four top…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

£20,000 invested in AstraZeneca shares 5 years ago is now worth…

AstraZeneca shares have more than doubled since 2021 -- but they still look very undervalued. Here’s why forecast earnings growth…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

£10,000 invested in Micron stock six months ago is now worth…

Dr James Fox talks about Micron stock -- one of his best investments over the past six months. Does he…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

100%+ earnings growth and a P/E of 8.5? Could this be a once-in-a-decade stock market gift for value investors?

As the UK stock market makes a go at a recovery, Mark Hartley identifies one FTSE 250 stock that could…

Read more »